Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology

SAN CARLOS, Calif.–(BUSINESS WIRE)– #DNAinnovation–GSK has signed a collaboration & licensing agreement to leverage Elegen’s cell-free DNA manufacturing tech in the dev of GSK’s vaccines & medicines.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks